The prevalence of non-alcoholic fatty liver disease in healthy young persons

OKUR, Gokcan; Karacaer, Zehra

The prevalence of non-alcoholic fatty liver disease in healthy young persons

Gokcan OKUR, (Department of Radiology, Etimesgut Military Hospital, Ankara, Turkey)

Zehra KARACAER (Department of Infectious Diseases and Clinical Microbiology, Etimesgut Military Hospital, Ankara, Turkey)

İstanbul Kuzey Klinikleri

4 0

Yıl: 2016 Cilt: 3 Sayı: 2 Sayfa Aralığı: 111 - 117 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

The prevalence of non-alcoholic fatty liver disease in healthy young persons

Öz:

OBJECTIVE: This aim of the present study was to determine prevalence of non-alcoholic fatty liver disease (NAFLD) in healthy young persons admitted for annual medical check-ups.METHODS: A retrospective study was conducted in a military hospital. Total of 254 healthy males were included and participants were divided into 2 groups according to presence and grade of NAFLD. Demographic data, biochemical test results, and ultrasonography findings were collected from all patients. Statistical analyses were performed using SPSS software, version 22.0 (SPSS, Inc., Chicago, IL, USA).RESULTS: Prevalence of NAFLD was 10.6%. Significant differences were found with regard to age; levels aspartate transaminase, alanine transaminase, gamma-glutamyl transferase, and alkaline phosphatase; body mass index (BMI); and presence of NAFLD (p=0.014, p=0.022, p=0.003, p≤0.001, p=0.004, and p≤0.001, respectively). When compared to those with grade 1 NAFLD, levels of alanine transaminase, fasting blood glucose, gammaglutamyl transferase, triglycerides, total cholesterol and age variables were higher in those with grade 2 NAFLD. However, no statistically significant difference was noted when comparing grades of NAFLD.CONCLUSION: Though this study included patients with normal BMI and normal laboratory test results, presence of NAFLD was not rare in these otherwise healthy young men. Liver enzyme levels were within normal limits; however, there was slight tendency to be high consistent with presence and grade of NAFLD

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Yüksel F, Türkkan D, Yüksel I, Kara S, Celik N, Samdancı E. Fatty liver disease in an autopsy series of children and adolescents. Hippokratia 2012;16:61–5.
2. Arslan N, Büyükgebiz B, Oztürk Y, Cakmakçi H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005;47:23–7. 3. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. American Family Physician 2006;73:11.
4. Kara M, Erdal M. A public health issue that increased prevalence: Non-alcoholic fatty liver disease. TAF Prev Med Bull 2014;13:65–76.
5. Celebi S, Ataseven H, Mengucuk E, Deveci SH, Acık Y, Bahcecioglu İH. Epidemic features of nonalcoholic fatty liver in urban community of Elazıg. Akademik Gastroenteroloji Dergisi 2006;5:41–6.
6. Uyanikoglu A, Coskun M, Binici DN, Ozturk Y. The frequency of hepatosteatosis in inactive hepatitis b carries. Viral Hepatitis Journal 2011;17:62–5. 116 North Clin Istanbul – NCI
7. Demir ME, Aydogan T, Pamukcu M, Ulas T, Eren MA. Ultrasound evaluation of metabolic syndrome patients with hepatosteatosis. Journal of clinical and Experimental Investigations 2013;4:153–8.
8. Kaya E, Demir D, Alahdab YO, Yilmaz Y. Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter. Eur J Gastroenterol Hepatol 2016;28:1264–7.
9. Incedayı M, Pekkafali MZ, Sildiroglu HO, Basekim CC, Kizilkaya E. Sonographic and histopathological correlation in diffused fatty liver. Anatol J Clin Investig 2012;6:1–5.
10. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Digestive Diseases and Sciences January 2005.
11. Puri P, Sanyal AJ. Nonalcoholic fatty liver disease: definitions, risk factors, and workup, (review). Clinical Liver Disease 2012;1:4.
12. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549–55.
13. Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol 2008;23:779–82.
14. Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36:1825–35.
15. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433–45.
16. Sarikaya S, Vurdem UE, Erdem FH, Inci F, Erdem A. Relationship between the extent of coronary artery disease and fatty liver severity in nonalcoholic fatty liver disease patient. AIBU Izzet Baysal Tıp Fakultesi Dergisi 2012:7:1–3.
17. Agarwal AK, Jain V, Singla S, Baruah BP, Arya V, Yadav R, Singh VP. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India 2011;59:351–4.
18. Mohammadi A, Bazazi A, Maleki-Miyandoab T, GhasemiRad M. Evaluation of relationship between grading of fatty liver and severity of atherosclerotic finding. Int J Clin Exp Med 2012;5:251–6.
19. Abangah G, Yousefi A, Asadollahi R, Veisani Y, Rahimifar P, Alizadeh S. Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease. Iran Red Crescent Med J 2014;16:12669.
20. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010;28:155–61.
21. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286–92.
22. Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012.
23. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008;48:792–8.
24. Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, et al. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon 2011;11:452–8.
25. Korkmaz P, Aykın N, Cevik FC, Alpay Y, Naz H, Gulduren HM. Hepatic Steatosis in Inactive Hepatitis B Carriers: Prevalence, Evaluation of Viral and Biochemical Parameters. Viral Hepatitis Journal 2013;19.
26. Inci A, Meral CE. Ultrasonographic assessment of the prevalence of hepatic steatosis in inactive hepatitis B carriers. Viral Hepatitis Journal 2013;19:46–8.
27. Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980;53:440–2.
28. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26–31.
29. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292:13–5.
30. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006;38:485–9.

APA	OKUR G, Karacaer Z (2016). The prevalence of non-alcoholic fatty liver disease in healthy young persons. , 111 - 117.
Chicago	OKUR Gokcan,Karacaer Zehra The prevalence of non-alcoholic fatty liver disease in healthy young persons. (2016): 111 - 117.
MLA	OKUR Gokcan,Karacaer Zehra The prevalence of non-alcoholic fatty liver disease in healthy young persons. , 2016, ss.111 - 117.
AMA	OKUR G,Karacaer Z The prevalence of non-alcoholic fatty liver disease in healthy young persons. . 2016; 111 - 117.
Vancouver	OKUR G,Karacaer Z The prevalence of non-alcoholic fatty liver disease in healthy young persons. . 2016; 111 - 117.
IEEE	OKUR G,Karacaer Z "The prevalence of non-alcoholic fatty liver disease in healthy young persons." , ss.111 - 117, 2016.
ISNAD	OKUR, Gokcan - Karacaer, Zehra. "The prevalence of non-alcoholic fatty liver disease in healthy young persons". (2016), 111-117.

APA	OKUR G, Karacaer Z (2016). The prevalence of non-alcoholic fatty liver disease in healthy young persons. İstanbul Kuzey Klinikleri, 3(2), 111 - 117.
Chicago	OKUR Gokcan,Karacaer Zehra The prevalence of non-alcoholic fatty liver disease in healthy young persons. İstanbul Kuzey Klinikleri 3, no.2 (2016): 111 - 117.
MLA	OKUR Gokcan,Karacaer Zehra The prevalence of non-alcoholic fatty liver disease in healthy young persons. İstanbul Kuzey Klinikleri, vol.3, no.2, 2016, ss.111 - 117.
AMA	OKUR G,Karacaer Z The prevalence of non-alcoholic fatty liver disease in healthy young persons. İstanbul Kuzey Klinikleri. 2016; 3(2): 111 - 117.
Vancouver	OKUR G,Karacaer Z The prevalence of non-alcoholic fatty liver disease in healthy young persons. İstanbul Kuzey Klinikleri. 2016; 3(2): 111 - 117.
IEEE	OKUR G,Karacaer Z "The prevalence of non-alcoholic fatty liver disease in healthy young persons." İstanbul Kuzey Klinikleri, 3, ss.111 - 117, 2016.
ISNAD	OKUR, Gokcan - Karacaer, Zehra. "The prevalence of non-alcoholic fatty liver disease in healthy young persons". İstanbul Kuzey Klinikleri 3/2 (2016), 111-117.